Abiopharma

🔍 MATHIS STEVEN B (Executive)

Company: American Integrity Insurance Group, Inc. (AII)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 778 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 3,126.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents shares of restricted stock of American Integrity Insurance Group, Inc. granted to the reporting person under the American Integrity Insurance Group, Inc. 2025 Long-Term Incentive Plan as director compensation.